The Covid-19 vaccine co-developed by Pfizer has sought emergency-use approval in Hong Kong. Photo: EPA-EFE The Covid-19 vaccine co-developed by Pfizer has sought emergency-use approval in Hong Kong. Photo: EPA-EFE
The Covid-19 vaccine co-developed by Pfizer has sought emergency-use approval in Hong Kong. Photo: EPA-EFE

Coronavirus: Hong Kong panel recommends Pfizer-BioNTech vaccine for use, but seeks more information over Norway deaths

  • Unanimous backing from experts will go before health secretary for final decision, paving way for mass inoculation drive from mid-February
  • Panel chairman says Pfizer-BioNTech vaccine’s benefits outweigh risks, but adds it will request more information from Norway on deaths there

Topic |   Coronavirus pandemic
The Covid-19 vaccine co-developed by Pfizer has sought emergency-use approval in Hong Kong. Photo: EPA-EFE The Covid-19 vaccine co-developed by Pfizer has sought emergency-use approval in Hong Kong. Photo: EPA-EFE
The Covid-19 vaccine co-developed by Pfizer has sought emergency-use approval in Hong Kong. Photo: EPA-EFE
READ FULL ARTICLE